600276 恒瑞醫藥
按盤價 
55.180 +3.550 (+6.876%) | 2025/12 - 人民幣(K¥) | 變動 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 31,629,416 | 13.02% | 22,819,785 | 21,275,271 | 25,905,526 | 27,734,599 | |
| 減：營業總成本 | 23,093,098 | 9.93% | 18,214,153 | 17,747,084 | 21,792,969 | 21,282,046 | |
| 其中:營業成本 | 4,362,656 | 13.37% | 3,525,248 | 3,486,639 | 3,741,799 | 3,348,690 | |
| 財務費用 | (406,945) | -28.95% | (478,390) | (470,867) | (337,956) | (181,744) | |
| 資產減值損失 | (86,914) | 167.11% | (107,217) | (146,684) | (13,861) | (7,278) | |
| 公允價值變動收益 | 173,574 | 59.78% | (58,257) | 76,503 | 36,233 | 16,497 | |
| 投資收益 | (80,185) | -1,973.76% | (49,157) | 387,365 | 213,434 | 341,425 | |
| 其中：對聯營企業和合營企業的投資收益 | (97,143) | 350.14% | (72,696) | (62,996) | (6,940) | -- | |
| 營業利潤 | 8,990,003 | 20.02% | 4,909,905 | 4,111,960 | 4,664,816 | 7,007,072 | |
| 利潤總額 | 8,707,626 | 21.45% | 4,667,110 | 3,968,492 | 4,466,309 | 6,895,480 | |
| 減：所得稅費用 | 990,623 | 18.97% | 389,289 | 153,351 | (17,718) | 586,587 | |
| 淨利潤 | 7,717,002 | 21.78% | 4,277,821 | 3,815,142 | 4,484,027 | 6,308,893 | |
| 減：非控股權益 | 5,947 | 1,171.82% | (24,615) | (91,233) | (46,191) | (19,490) | |
| 股東淨利潤 | 7,711,055 | 21.69% | 4,302,436 | 3,906,375 | 4,530,218 | 6,328,383 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.190 | 19.00% | 0.680 | 0.610 | 0.710 | 0.990 | |
| 每股派息 (元) * | 0.200 | 0.00% | 0.200 | 0.160 | 0.160 | 0.200 | |
| 每股淨資產 (元) * | 9.232 | 29.37% | 6.344 | 5.929 | 5.473 | 5.721 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 27/03/2026 16:06 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
